Aflac Incorporated (NYSE:AFL – Get Free Report) Director Masatoshi Koide sold 32,000 shares of the firm’s stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $80.32, for a total value of $2,570,240.00. Following the sale, the director now directly owns 55,598 shares of the company’s stock, valued at approximately $4,465,631.36. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Aflac Stock Down 0.1 %
Shares of NYSE AFL opened at $81.43 on Tuesday. Aflac Incorporated has a 52 week low of $60.20 and a 52 week high of $82.71. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.08 and a current ratio of 0.08. The stock’s fifty day moving average is $77.99 and its 200 day moving average is $73.03. The stock has a market capitalization of $47.59 billion, a P/E ratio of 10.73, a PEG ratio of 2.00 and a beta of 0.89.
Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Thursday, November 2nd. The financial services provider reported $1.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.44 by $0.40. Aflac had a return on equity of 17.86% and a net margin of 24.17%. The firm had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.31 billion. During the same quarter in the previous year, the business posted $1.23 earnings per share. The business’s revenue for the quarter was up 5.2% on a year-over-year basis. Sell-side analysts forecast that Aflac Incorporated will post 6.25 earnings per share for the current fiscal year.
Aflac Dividend Announcement
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Bank Julius Baer & Co. Ltd Zurich boosted its stake in shares of Aflac by 99,608.4% during the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,691,395,636 shares of the financial services provider’s stock valued at $118,059,415,000 after purchasing an additional 1,689,699,293 shares in the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of Aflac by 338.0% during the first quarter. Envestnet Asset Management Inc. now owns 5,604,901 shares of the financial services provider’s stock valued at $93,656,000 after purchasing an additional 4,325,212 shares in the last quarter. First Trust Advisors LP boosted its stake in shares of Aflac by 71.2% during the first quarter. First Trust Advisors LP now owns 6,512,084 shares of the financial services provider’s stock valued at $420,160,000 after purchasing an additional 2,707,608 shares in the last quarter. Norges Bank acquired a new stake in shares of Aflac during the fourth quarter valued at about $175,416,000. Finally, Invesco Ltd. boosted its stake in shares of Aflac by 62.4% during the first quarter. Invesco Ltd. now owns 4,936,608 shares of the financial services provider’s stock valued at $317,865,000 after purchasing an additional 1,897,212 shares in the last quarter. Institutional investors own 66.75% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have issued reports on AFL. Bank of America raised their price target on Aflac from $79.00 to $86.00 in a report on Wednesday, August 2nd. Wells Fargo & Company increased their price objective on Aflac from $71.00 to $78.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 15th. Jefferies Financial Group increased their price objective on Aflac from $70.00 to $74.00 and gave the stock a “hold” rating in a research report on Thursday, September 14th. Raymond James increased their price objective on Aflac from $77.00 to $83.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 26th. Finally, Citigroup increased their price objective on Aflac from $69.00 to $76.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 9th. Seven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $77.80.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
- Five stocks we like better than Aflac
- How to Invest in Grocery Stores
- Catch the dip on Sociedad Quimica before earnings?
- Investing in large cap stocks: Diving into big caps
- Can new GPT store spur generative AI monetization?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Energy looks to dominate markets with 3 oil and gas stocks
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.